Pharma Giants Spent $130M+ on Lobbying in 2025 for TrumpRx Drug Pricing Plan
Pharmaceutical companies backing TrumpRx spent over $130 million on federal lobbying in 2025, a 23% surge. Eli Lilly paused its obesity awareness camp...
Xeber.world
Mounjaro
- electric vehicles
- automotive industry
- Stellantis
- collector cars
- automotive history
- Limited Edition
- classic cars
- Mecum Auctions
- supercar
- Formula 1
- Donald Trump
- AI ethics
- U.S. China relations
- AI adoption
- AI regulation
- artificial intelligence
- Trump administration
- inflation
- AI governance
- AI in business
- Bitcoin
- crypto regulation
- Senate Banking Committee
- CLARITY Act
- digital assets
- Digital Asset Market Clarity Act
- Federal Reserve
- Bitcoin price
- Bitcoin ETF
- crypto market
- AI cybersecurity
- cybersecurity
- CISA
- enterprise security
- CVE-2026-41089
- CVE-2026-41096
- Canvas data breach
- Instructure
- House Homeland Security Committee
- Donald Trump
- Netflix
- late-night TV
- Disney
- Paramount
- Cannes Film Festival
- Stephen Colbert
- Prime Video
- Jimmy Kimmel
- Marvel
- climate change
- renewable energy
- energy policy
- AI data centers
- geothermal energy
- Fervo Energy
- U.S. energy policy
- Strait of Hormuz
- Jason Bordoff
- Texas drought
- Subnautica 2
- Phasmophobia
- gaming news
- R.E.P.O.
- Forza Horizon 6
- FC 26
- Subnautica 2 tips
- Subnautica 2 guide
- Alan Wake event
- Destructoid
- FDA
- public health
- Marty Makary
- Trump administration
- healthcare policy
- Kyle Diamantas
- hantavirus
- health policy
- FDA leadership
- gene therapy
- Donald Trump
- Trump administration
- Supreme Court
- gerrymandering
- Iran war
- Voting Rights Act
- 2024 election
- Republican Party
- Virginia Supreme Court
- redistricting
- AI ethics
- climate change
- Elon Musk
- OpenAI
- ChatGPT
- tech industry
- Tesla
- remote sensing
- AI in the workplace
- generative AI
France Fines Novo Nordisk and Eli Lilly Over Misleading Weight Loss Drug Ads
France’s medicines regulator has fined Novo Nordisk $2 million and Eli Lilly $127,000 for allegedly misleading advertisements for their weight loss dr...
FDA Proposes Ban on Compounded Obesity and Diabetes Drugs, Names New Acting Director
The FDA proposed excluding semaglutide and tirzepatide from compounding lists, citing no clinical need. Katherine Szarama was named acting director of...
FDA Proposes Ban on Compounded Weight-Loss Drugs, Targeting Semaglutide and Tirzepatide
The FDA has proposed excluding semaglutide and tirzepatide, key ingredients in popular weight-loss and diabetes drugs like Wegovy, Ozempic, Mounjaro,...
Study Reveals Mounjaro Causes More Lean Body Mass Loss Than Ozempic—Here’s Why It Matters
A new study suggests tirzepatide medications like Mounjaro may lead to greater lean body mass loss compared to semaglutide drugs like Ozempic. Researc...
Tirzepatide Drugs Mounjaro and Zepbound Reduce Cardiovascular Risks in High-Risk Patients
New research reveals that GLP-1 medications containing tirzepatide, such as Mounjaro and Zepbound, significantly lower cardiovascular risks in patient...
Medicare Scraps Obesity Drug Pilot After Insurer Pushback; Amazon Launches GLP-1 Access Program
The Trump administration's Medicare obesity drug pilot was abandoned after insurers declined to participate. Meanwhile, Amazon's One Medical is launch...